Regina Readling

Biography

Regina Readling
Regina Readling is an Executive Compensation & Benefits partner in Weil’s Tax Department and is based in New York. Regina’s practice focuses on the executive compensation and employee benefits aspects of corporate transactions, including mergers and acquisitions, divestitures, initial public offerings and other strategic transactions. In addition to her significant transactional practice, Regina has experience advising on a broad range of public and private company compensation issues and routinely counsels companies, boards of directors, compensation committees and executives on tax, securities law, disclosure and corporate governance matters pertaining to executive compensation arrangements.

Experience*

  • Allianz in its $1 billion asset sale of the personal lines insurance business of Fireman’s Fund Insurance Company to ACE
  • Amazon.com in its $13.7 billion acquisition of Whole Foods Market and its acquisition of PillPack
  • American Express in its acquisition of substantially all of Kabbage
  • Apollo Education Group in its $1.1 billion going private transaction
  • Bausch Health (f/k/a Valeant Pharmaceuticals) in its $15.8 billion acquisition of Salix Pharmaceuticals
  • Better HoldCo in its $6.9 billion pending sale to Aurora Acquisition Corp., a SPAC sponsored by Novator Capital
  • The Bank of New York Mellon Corporation in the sale of its HedgeMark business to Innocap Investment Management
  • Canadian Pacific Railway in its $31 billion acquisition of Kansas City Southern
  • Concho Resources in its $13.7 billion sale to ConocoPhillips and its $9.5 billion acquisition of RSP Permian
  • Crescent Capital Group in its up to $338 million sale of a majority stake to Sun Life Financial
  • Cytec Industries in its $5.5 billion sale to Solvay
  • Diageo in its $1 billion acquisition of Casamigos
  • Dyax in its $5.9 billion sale to Shire
  • Enbridge in its $28 billion acquisition of Spectra Energy
  • Endo International in its $3 billion acquisition of Auxilium Pharmaceuticals
  • EverBank in its $2.5 billion sale to Teachers Insurance and Annuity Association of America
  • First Horizon Corporation in its pending $13.4 billion sale to TD Bank Group
  • Fiserv in its $22 billion acquisition of First Data Corporation
  • Goldman Sachs in its €1.7 billion acquisition of NN Investment Partners; its approximately $1.13 billion acquisition of People Corporation; and its acquisitions of Clarity Money and GE Capital Bank’s online deposit platform and assumption of its online deposits
  • Harris Corporation in its $35 billion merger of equals with L3 Technologies to form L3Harris Technologies and its $350 million sale of its Night Vision business to Elbit Systems of America (a subsidiary of Elbit Systems)
  • HSBC Holdings in the sales of its East and West Coast Retail Branch Network to Citizens Bank and Cathay Bank, respectively
  • Investor group led by entrepreneur and sports card collector Nat Turner, D1 Capital Partners and Cohen Private Ventures in its $853 million acquisition of Collectors Universe
  • K+S Aktiengesellschaft in its $3.2 billion sale of its Americas salt business to Stone Canyon Industries Holdings, Mark Demetree and affiliates
  • KCG Holdings in its $1.4 billion sale to Virtu Financial
  • Kite Pharma in its $11.9 billion sale to Gilead Sciences
  • The Kroger Company in its pending $24.6 billion merger with Albertsons Companies, Inc.
  • Ladenburg Thalmann Financial Services in its $1.3 billion sale to Advisor Group
  • Merck KGaA in its $6.4 billion acquisition of Versum Materials
  • NorthStar Asset Management Group in its $6 billion merger of equals with DigitalBridge Group (f/k/a Colony Capital) and NorthStar Realty Finance
  • Perrigo Company in its $9 billion acquisition of Elan Corporation
  • The Priceline Group in its $2.6 billion acquisition of OpenTable
  • Regions Bank in its $1 billion acquisition of EnerBank USA
  • Royal Philips in multiple transactions, including its $2.8 billion acquisition of BioTelemetry and its $2 billion acquisition of The Spectranetics Corporation
  • Sotheby’s in its $3.7 billion sale to BidFair USA
  • SVB Financial Group in its approximately $900 million acquisition of Boston Private Financial Holdings
  • Valeant Pharmaceuticals in its $14.5 billion acquisition of Salix Pharmaceuticals

Regina is an active member of the SUNY Buffalo Law School Alumni NYC Steering Committee and the Buffalo Law Review Alumni Board of Consultants and has also served as a mentor for students enrolled in SUNY Buffalo Law School’s Program in Finance and Law.

Regina received her J.D., magna cum laude, from SUNY Buffalo Law School and her B.S., cum laude, from Bates College.

*Includes matters handled prior to joining Weil.

Firm News & Announcements

Firm News & Announcements